The global marijuana industry continues to develop at an impressive pace, driven by new developments in the field of cannabis-based pharmaceutics.
As a result, M&A activity in the market is heading toward exponential growth as well.
Articles
Rising India Inc. Enters the $6.5 Billion Cannabis Industry
Rising India Inc. (OTC: RSII) announced that the company is targeting opportunities in the cannabis industry. The company is in active negotiations to reach a Letter of Intent with business operators that are currently active in the cannabis industry.
SinglePoint, Inc. (SING) CEO Featured in Exclusive Audio Interview with NetworkNewsWire
Multifaceted financial news and publishing company NetworkNewsWire this morning announced the availability of a new audio interview with SinglePoint, Inc. (OTC: SING) CEO Greg Lambrecht.
New Bill Introduced To End Federal Cannabis Prosecution
Republican Congressman Dana Rohrabacher of California recently submitted a piece of legislation in the U.S. House of Representatives targeted at preventing the federal government from enforcing states that have legalized cannabis for recreational or medical use.
ChineseInvestors.com (CIIX) Issues Update on Recent Financial and Business Achievements
ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning issued a news release highlighting some of its financial and business achievements for January 2017, as well as its plans to build on these milestones moving forward.
SinglePoint, Inc. (SING) CEO Discusses Recent Share Price Increase in Interview on MoneyTV
Full-service mobile technology and marketing provider SinglePoint, Inc. (OTC: SING) this morning was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon.
A Tetra Bio-Pharma and IntelGenx Combine for New Drug Development
Tetra Bio-Pharma Inc. (CSE: TBP, OTC:GRPOF) and IntelGenx Corp. (TSXV:IGX, OTCQX:IGXT), annouced the signing of a binding term sheet for the development and commercialization of a drug product containing dronabinol.
Invictus MD announces binding LOI to acquire 100% of a Late Stage Applicant under Health Canada’s ACMPR
INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that on February 6, 2017 it had entered into a binding letter of intent (“LOI”) for an option to acquire 100% (the “Option”) of the outstanding shares of a Late Stage Applicant (the “OptionCo”) under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) from its current shareholders (the “Vendors”).
SinglePoint, Inc. Eliminates Debt, Issues Update on Fund Raising Initiatives and Allocations
Tweet Share SEATTLE, WA / ACCESSWIRE / February 7, 2017 / SinglePoint, Inc. (OTC PINK: SING), a full-service mobile technology and marketing provider, today announces that the Company is officially debt-free. In conjunction, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure additional funding of $1 million.
Disruptive Technology: Here’s The Future $PKG $WEED $MYM $PTNYF
Ding Dong: Here’s Your Pot. In the world of new and disruptive technologies, there are a few ideas that just make a lot of sense to everyone. And sure enough, several have become overnight sensations creating unimaginable wealth (especially for early investors), while changing the landscape completely. The funny thing is, they often don’t rely on infrastructure or conventional business models at all.
Crown Baus (OTC:CBCA) to Spend Upwards of $6m on Greenhouse Space
Crown Baus Capital Corp. (OTC:CBCA) is negotiating investment opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada.
Phase 1 for each one acre build-out will cost approximately $300,000 to $500,000 USD with full production capacity maxing out at approximately 33,000 sq. ft.
Invictus MD (CSE:IMH, OTC:IVITF) Aquires 150 acres to Increase Production
Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares of a late stage applicant ("OptionCo") from its current shareholders. OptionCo has built 60,000 square feet of secured perimeter for its current production facility located on 150 acres, which is expected to have production capacity of up to 6,000 kg per annum. OptionCo has already submitted plans for additional buildings on the Property including a 30,000 square foot facility.
Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry
Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry 07/02/2017 14:30 PALM BEACH, Florida , February 7, 2017 /PRNewswire/ -- The injection of modern technology into the developing world of cannabis and legal medical marijuana is helping the industry climb to new heights and increase engagement with consumers, especially when it comes to cannabis patients in the medical facet of the industry.
Greatest Stoner Valentine’s Day Gift Guide
People are waking up to the fact that cannabis can enhance their sex lives, with more research emerging to back up the traditional use of marijuana as an aphrodisiac. Beyond increasing feelings of sensuality and improving mood, using the herb medicinally lessens pain, anxiety and helps users center themselves in the moment and relax—which is why more businesses are developing cannabis-infused topicals and edibles meant to do just that.
Ex-Medical Marijuana Officials Charged for Illegal Shipment
BY KYLE POTTER ASSOCIATED PRESS
ST. PAUL, Minn. (AP) — Prosecutors in Minnesota filed felony charges Monday against two former officials from one of the state’s licensed medical marijuana manufacturers for allegedly shipping marijuana oil to a subsidiary facility in New York.